Cargando…

Sanggenon C protects against pressure overload-induced cardiac hypertrophy via the calcineurin/NFAT2 pathway

The effects of Sanggenon C on oxidative stress and inflammation have previously been reported; however, little is currently known regarding the effects of Sanggenon C on cardiac hypertrophy and fibrosis. In the present study, aortic banding (AB) was performed on mice to induce cardiac hypertrophy. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Lili, Gu, Yulei, Gao, Lu, Shangguan, Jiahong, Chen, Yang, Zhang, Yanzhou, Li, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647066/ https://www.ncbi.nlm.nih.gov/pubmed/28849031 http://dx.doi.org/10.3892/mmr.2017.7288

Ejemplares similares

Rutaecarpine Ameliorates Pressure Overload Cardiac Hypertrophy by Suppression of Calcineurin and Angiotensin II
por: Li, Shujun, et al.
Publicado: (2021)

Gestational diabetes triggers postpartum cardiac hypertrophy via activation of calcineurin/NFAT signaling
por: Verma, Nirmal, et al.
Publicado: (2021)

Sanggenon C protects against cardiomyocyte hypoxia injury by increasing autophagy
por: Gu, Yang, et al.
Publicado: (2017)

Long‐term administration of pyridostigmine attenuates pressure overload‐induced cardiac hypertrophy by inhibiting calcineurin signalling
por: Lu, Yi, et al.
Publicado: (2017)

Testin protects against cardiac hypertrophy by targeting a calcineurin‐dependent signalling pathway
por: Gao, Lu, et al.
Publicado: (2018)

Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy
por: Luo, Yuxuan, et al.
Publicado: (2021)

Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy
por: Lunde, Ida G., et al.
Publicado: (2022)

Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway
por: Yoon, Jung Joo, et al.
Publicado: (2020)

Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy
por: Bernt, Alexander, et al.
Publicado: (2016)

Microtubule Stabilization in Pressure Overload Cardiac Hypertrophy
por: Sato, Hiroshi, et al.
Publicado: (1997)

Steric Effect of Antioxidant Diels-Alder-Type Adducts: A Comparison of Sanggenon C with Sanggenon D
por: Li, Xican, et al.
Publicado: (2018)

Cytosolic CARP Promotes Angiotensin II- or Pressure Overload-Induced Cardiomyocyte Hypertrophy through Calcineurin Accumulation
por: Chen, Ci, et al.
Publicado: (2014)

Protective Roles of Interferon‐γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload
por: Kimura, Akihiko, et al.
Publicado: (2018)

Eosinophils protect pressure overload- and β-adrenoreceptor agonist-induced cardiac hypertrophy
por: Yang, Chongzhe, et al.
Publicado: (2022)

Connective Tissue Growth Factor Overexpression in Cardiomyocytes Promotes Cardiac Hypertrophy and Protection against Pressure Overload
por: Panek, Anna N., et al.
Publicado: (2009)

Angiotensin‐Converting Enzyme 3 (ACE3) Protects Against Pressure Overload‐Induced Cardiac Hypertrophy
por: Yu, Chang‐Jiang, et al.
Publicado: (2016)

Calcineurin/NFAT signalling inhibits myeloid haematopoiesis
por: Fric, Jan, et al.
Publicado: (2012)

2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy
por: Maayah, Zaid H., et al.
Publicado: (2018)

Tanshinone IIA Protects Against Cardiac Hypertrophy via Inhibiting Calcineurin/Nfatc3 Pathway
por: Tan, Xueying, et al.
Publicado: (2011)

Syndecan-4 Is Essential for Development of Concentric Myocardial Hypertrophy via Stretch-Induced Activation of the Calcineurin-NFAT Pathway
por: Finsen, Alexandra V., et al.
Publicado: (2011)

Correction: Connective Tissue Growth Factor Overexpression in Cardiomyocytes Promotes Cardiac Hypertrophy and Protection against Pressure Overload
por: Panek, Anna N., et al.
Publicado: (2009)

A NFAT decoy approach to inhibit cardiac hypertrophy
por: Heineke, Joerg
Publicado: (2021)

Balanced interactions of calcineurin with AKAP79 regulate Ca(2+)–calcineurin–NFAT signaling
por: Li, Huiming, et al.
Publicado: (2012)

A polypeptide inhibitor of calcineurin blocks the calcineurin-NFAT signalling pathway in vivo and in vitro
por: Wang, Ping, et al.
Publicado: (2021)

Astrocyte Activation and the Calcineurin/NFAT Pathway in Cerebrovascular Disease
por: Kraner, Susan D., et al.
Publicado: (2018)

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Xu, Si-Chi, et al.
Publicado: (2017)

Knockout of AMPKα2 Blocked the Protection of Sestrin2 Overexpression Against Cardiac Hypertrophy Induced by Pressure Overload
por: Zhang, Nan, et al.
Publicado: (2021)

How does NFAT3 regulate the occurrence of cardiac hypertrophy?
por: Hui, Wang, et al.
Publicado: (2023)

Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
por: Guo, Xinji, et al.
Publicado: (2020)

Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy
por: Ma, Sai, et al.
Publicado: (2021)

Cardiac Expression of Factor X Mediates Cardiac Hypertrophy and Fibrosis in Pressure Overload
Publicado: (2022)

AAV-mediated expression of NFAT decoy oligonucleotides protects from cardiac hypertrophy and heart failure
por: Remes, Anca, et al.
Publicado: (2021)

The role of Ca(2+)/Calcineurin/NFAT signalling pathway in osteoblastogenesis
por: Ren, Ranyue, et al.
Publicado: (2021)

Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling
por: Chen, Yuezhang, et al.
Publicado: (2017)

IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Dai, Jia, et al.
Publicado: (2013)

Intermedin Suppresses Pressure Overload Cardiac Hypertrophy through Activation of Autophagy
por: Chen, HuaLi, et al.
Publicado: (2013)

Effects of miRNA-455 on cardiac hypertrophy induced by pressure overload
por: WU, CHUNTAO, et al.
Publicado: (2015)

Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling
por: Liu, Xin, et al.
Publicado: (2021)

Apocynum Tablet Protects against Cardiac Hypertrophy via Inhibiting AKT and ERK1/2 Phosphorylation after Pressure Overload
por: Qi, Jianyong, et al.
Publicado: (2014)

Knockout of the ATPase inhibitory factor 1 protects the heart from pressure overload-induced cardiac hypertrophy
por: Yang, Kevin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6p6tseer39mk8c1lehacp977mg